Narra J
Vol. 1 No. 3 (2021): December 2021

Global acceptance and hesitancy of COVID-19 vaccination: A narrative review

Hassan , Wardah (Unknown)
Kazmi, Syeda K. (Unknown)
Tahir, Muhammad J. (Unknown)
Ullah , Irfan (Unknown)
Royan, Hibban Ar (Unknown)
Fahriani, Marhami (Unknown)
Nainu, Firzan (Unknown)
Rosa, Sandro GV. (Unknown)



Article Info

Publish Date
07 Dec 2021

Abstract

The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major global health threat to human civilization and has disrupted many aspects of the community around the globe. Vaccination is one of the prominent measures to control the COVID-19 pandemic. More than 120 vaccines have entered human clinical trials and at least 8 vaccines have been fully approved. However, the success of the COVID-19 vaccination programs depends on how the community accepts the vaccines. Despite COVID-19 vaccination having been initiated for a while now, more than 50% of the global population have not been vaccinated. In some low- and middle-income countries (LMICs), the vaccine coverage is less than 20%. Since the decision to accept the new vaccine is complex, understanding the factors underpinning vaccine acceptance is critical. This review aimed to summarize the COVID-19 vaccine acceptance rate around the globe as well as its associated determinants. Information from this study might be important to formulate effective strategies to increase the COVID-19 vaccine coverage, and to be able to achieve herd immunity.

Copyrights © 2021






Journal Info

Abbrev

main

Publisher

Subject

Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Description

Narra J is a multidisciplinary journal and it is published three times (April, August, December) a year. The objective is to promote articles on infection, public health, global health, tropical infection, one health and diseases in tropics. Narra J publishes original research work across all ...